Haemonetics | HAE - Des Atouts

Prix De L'Action
59.61
Variation Quotidienne
1.03 1.76%
Mensuellement
-3.36%
Annuel
-7.51%
Q1 Prévisions
56.82




Des Atouts Changement Date
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cerus USD 215.18M 2.11M 2025-09
Cooper Companies USD 12.42B 29.4M 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
Hologic USD 9.18B 165.8M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Neogen USD 3.36B 18.21M 2025-09
OraSure Technologies USD 403.17M 19.93M 2025-12
Plus Therapeutics USD 11.39M 1.89M 2023-12
Quidel USD 5.77B 94.2M 2025-12
ResMed USD 8.5B 195.02M 2025-12
STAAR Surgical USD 451.68M 4.68M 2025-12
Steris USD 10.59B 180.7M 2025-12
Stryker USD 47.84B 787M 2025-12
Surmodics USD 178.56M 1.15M 2024-09
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
US Physical Therapy USD 1.2B 7.74M 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12